Accurately identifying left ventricular fibrosis is paramount for diagnostic, prognostic and procedural reasons. Increasing evidence for the benefit of 3D whole heart imaging in fibrosis identification is emerging. Limitations to integrating 3D whole heart imaging into routine practice include risking suboptimal imaging incumbering diagnostic value. We undertook retrospective quantitative and qualitative analysis of clinically indicated paired 2D and 3D imaging. Quantitative SNRscar and CNRscar-myo analysis was not significantly different and qualitative diagnostic utility was comparable both in patients with ischaemic and non-ischaemic disease. This small study provides evidence for routine usage of 3D whole heart imaging for scar identification.